GLP-1 Costs8 min read·Published July 9, 2026

How Much Does Hers Weight Loss Cost? A Full Price Breakdown

A plain-English look at Hers oral kits, compounded semaglutide, brand-name GLP-1 costs, insurance, fees, and alternatives.

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
How Much Does Hers Weight Loss Cost? A Full Price Breakdown

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

Hers weight loss plans start around $69 per month for some oral kits and range from roughly $165–$249 per month for compounded GLP-1 injections on longer prepaid plans. Brand-name GLP-1s like Wegovy and Zepbound can cost about $1,000–$2,000 per month without insurance. Hers weight loss care is generally self-pay.[1]

Quick facts: Hers weight loss cost at a glance

Hers weight loss pricing depends on the medication path: oral medication kits, compounded semaglutide, or brand-name GLP-1 medicines. A useful starting number is about $69/month for some oral-kit plans when paid on a longer schedule, while injectable GLP-1 plans usually cost more.[1]

  • Oral kits are usually the lowest advertised monthly option. They may include medications that are FDA-approved for other conditions but used off-label for weight management in some cases.[7][8][9]
  • Compounded semaglutide via a 503A pharmacy may be offered when clinically appropriate. Compounded GLP-1s are not FDA-approved, and FDA-approved semaglutide products should not be viewed as the same as compounded products.[2]
  • Wegovy (semaglutide, a GLP-1 receptor agonist) is FDA-approved for chronic weight management in certain adults and adolescents. Zepbound (tirzepatide, a GIP/GLP-1 receptor agonist) is FDA-approved for chronic weight management in certain adults.[3][5]
  • Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not weight loss alone.[4][6]
  • Prices shown are current as of publication and may change. Check the provider’s site for the latest pricing before signing up.

How much does Hers weight loss cost per month?

Hers weight loss cost can be grouped into three buckets: oral kits, compounded GLP-1 injections, and brand-name GLP-1 injections. The main price gap is that brand-name GLP-1s may reach $1,000–$2,000/month without insurance, while oral kits and compounded options are often advertised at lower self-pay prices.[1][3][5]

Oral weight loss kit pricing

Hers oral weight loss kits are often advertised from about $69 per month on longer prepaid plans.[1] These kits may include medicines such as bupropion, naltrexone, metformin, or topiramate, depending on a clinician’s review. Some uses may be off-label for weight management, meaning the medicine is FDA-approved for another use but not specifically for that weight loss use.[7][8][9]

Oral medicines may support appetite or craving control for some people, but results vary and are not guaranteed. Side effects and cautions depend on the medicine: bupropion can raise seizure risk in certain people, naltrexone is not used with opioid treatment, metformin can cause stomach upset and has a rare lactic acidosis warning, and topiramate can cause birth-defect risks plus thinking or mood side effects.[7][8][9]

Compounded GLP-1 (semaglutide) pricing

Hers has advertised compounded semaglutide plans at lower monthly prices than many brand-name GLP-1 cash-pay options, with some longer prepaid plans around the mid-$100s to mid-$200s per month.[1] Semaglutide is the active ingredient in FDA-approved Ozempic and Wegovy, but compounded semaglutide is not FDA-approved.[2][3][4]

Semaglutide, a GLP-1 receptor agonist, has clinical trial evidence for weight loss in adults with obesity or overweight when paired with lifestyle changes. In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly plus lifestyle intervention; average weight loss was greater with semaglutide than placebo, but individual results vary.[10] In the same trial and FDA labeling, gastrointestinal side effects were common, and the Wegovy label includes warnings for pancreatitis, gallbladder disease, kidney injury from dehydration, and a boxed warning related to thyroid C-cell tumors in rodents.[3][10]

Brand-name GLP-1 pricing: Ozempic, Wegovy, Mounjaro, and Zepbound

Brand-name GLP-1 options through self-pay telehealth can be the highest-cost path. Ozempic (semaglutide, a GLP-1 receptor agonist) and Mounjaro (tirzepatide, a GIP/GLP-1 receptor agonist) are FDA-approved for type 2 diabetes, while Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management in specific patients.[3][4][5][6]

FDA labeling for Wegovy describes a dose-escalation schedule beginning at 0.25 mg once weekly and increasing to a maintenance dose of 2.4 mg once weekly.[3] FDA labeling for Zepbound describes 2.5 mg once weekly as the starting dosage and 5 mg, 10 mg, or 15 mg once weekly as maintenance dosages.[5] These numbers come from product labels, not personal dosing advice.

Wegovy and Zepbound have strong trial data for average weight loss in eligible adults, but benefits should not be viewed apart from risk. In the SURMOUNT-1 trial, participants received tirzepatide 5 mg, 10 mg, or 15 mg once weekly or placebo; average weight loss was greater with tirzepatide, but gastrointestinal side effects were common and individual results vary.[11] Wegovy and Zepbound labels include warnings for pancreatitis, gallbladder disease, kidney injury, severe gastrointestinal reactions, and a contraindication for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.[3][5]

What’s included in the Hers weight loss subscription?

Hers weight loss subscription pricing usually bundles the online intake, clinician review, messaging, prescription management if appropriate, and medication shipping. The important time period is the plan length, because longer prepaid plans may show a lower average monthly price but require more money upfront.[1]

Clinician evaluation and messaging

Telehealth prescribing starts with an online health intake and a licensed clinician review. This matters because GLP-1s and oral weight loss medicines have exclusions, drug interactions, pregnancy considerations, and warning signs that should be checked before prescribing.[3][5][7][8]

Medication shipping and refills

For eligible patients, Hers typically ships medication as part of the subscription model.[1] If the medication is compounded semaglutide, the product is prepared by a compounding pharmacy and is not FDA-approved; if it is a brand-name product such as Wegovy or Zepbound, it is an FDA-approved product for its labeled use.[2][3][5]

Coaching and app support

Some programs include app-based support, education, or coaching tools. These can help with habits, but they do not replace medical care. Obesity guidelines support combining medication, nutrition, activity, behavior change, and long-term follow-up when clinically appropriate.[12]

Does Hers accept insurance for weight loss?

Hers insurance coverage is usually simple: weight loss plans are generally self-pay, not billed through insurance. The key cost issue is that insurance coverage varies for brand-name GLP-1s, and many plans have prior authorization rules or may not cover weight-loss drugs.[1][12]

If you use a brand-name GLP-1, your insurance plan may treat Wegovy, Zepbound, Ozempic, and Mounjaro differently because their FDA-approved indications differ. Wegovy and Zepbound are labeled for chronic weight management in certain patients, while Ozempic and Mounjaro are labeled for type 2 diabetes, not weight loss alone.[3][4][5][6]

Are there hidden fees or upfront costs?

Hers fees are mostly tied to plan type, payment schedule, and medication choice. The biggest possible upfront cost is a multi-month prepaid plan, which can lower the displayed monthly average but may require paying several months at once.[1]

Monthly vs multi-month prepaid plans

A monthly plan may cost more per month but less upfront. A longer prepaid plan may show a lower monthly average, but you should check the total charge, renewal timing, refill cadence, and what happens if you stop early.[1]

Cancellation and refund policy

Before paying, read the cancellation and refund terms on the provider’s website. Medication subscriptions can have refill cutoffs, shipment timelines, and rules for prescription products that differ from normal online purchases.[1]

How does Hers compare to other GLP-1 telehealth programs?

GLP-1 telehealth programs differ by medication access, insurance support, pharmacy model, and ongoing care. A useful comparison point is whether the program offers compounded GLP-1s, brand-name GLP-1s, oral kits, or coaching only.[1][2][3][5]

Program typeTypical medication optionsInsurance modelWhat to check
HersOral kits, compounded semaglutide, and some brand-name GLP-1 access depending on availability and eligibilityUsually self-pay for weight loss plansTotal prepaid cost, medication type, refill rules, and whether the prescription is compounded or FDA-approved
Ro-style GLP-1 telehealthOften focuses on branded GLP-1 access, lab work, clinician visits, and insurance navigation depending on planMay offer insurance support, but medication coverage depends on the patient’s planMembership fee, lab costs, prior authorization support, and cash-pay backup options
Noom-style behavior programBehavior coaching, app support, and in some cases medication pathways through affiliated clinical servicesVaries by program and medication pathWhether medication is included, separate, or unavailable in your state
ChiaClinician-vetted telehealth for compounded GLP-1s and longevity peptides through licensed US 503A pharmacy partners with third-party potency and sterility testingSelf-pay model with clinician reviewEligibility, medication fit, compounded status, follow-up plan, and side-effect support
Local clinician or obesity-medicine clinicBrand-name medications, possible compounded options, nutrition support, and in-person exams when neededOften can bill insurance for visits; medication coverage variesVisit costs, insurance rules, lab work, and pharmacy access

Is Hers weight loss worth the cost?

Hers weight loss may be worth considering if you want a self-pay telehealth path, understand the total price, and are comfortable with the medication option offered after clinician review. The main value question is whether the plan’s monthly cost, support, safety review, and medication type fit your needs.[1]

For GLP-1 medicines, clinical trials show average weight-loss benefits for semaglutide and tirzepatide in eligible adults, but individual results vary.[10][11] These benefits must be weighed against side effects, contraindications, pregnancy considerations, cost, long-term use questions, and the fact that weight regain can occur after stopping medication.[3][5][13]

For oral kits, the lower price may be appealing, but the evidence and FDA status depend on the exact medicine or combination. A clinician should explain which parts are FDA-approved, which uses are off-label, likely side effects, and when to seek care.[7][8][9]

3-min quiz

Compare medication paths before you commit

If you are considering GLP-1 treatment, compare the total cost, FDA status, pharmacy source, follow-up care, and side-effect plan before choosing a program.

How to get compounded GLP-1s through a licensed provider

Compounded GLP-1 access should start with a licensed clinician, not a price alone. A key safety point is that 503A pharmacies can compound patient-specific medications under federal and state rules, but compounded semaglutide and compounded tirzepatide are not FDA-approved.[2]

A licensed provider should review your medical history, current medications, pregnancy plans, prior pancreatitis or gallbladder disease, kidney risk, and thyroid cancer history before considering a GLP-1. This is important because semaglutide and tirzepatide labels include gastrointestinal side effects, dehydration-related kidney risk, pancreatitis warnings, gallbladder warnings, and thyroid C-cell tumor contraindications.[3][5]

If a compounded option is considered, ask which pharmacy prepares it, whether the pharmacy is licensed, whether the product uses the correct active ingredient rather than a salt form, how potency and sterility are checked, and how side effects are handled.[2]

Frequently asked questions

3-min quiz

Talk with a licensed clinician

A clinician can help you understand whether oral medication, a brand-name GLP-1, or a compounded GLP-1 is appropriate based on your health history and goals.

References

  1. 1.Hims & Hers Health. Hers Weight Loss pricing and treatment information. Hims & Hers Health, 2026.
  2. 2.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA, 2025.
  3. 3.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration, 2024.
  4. 4.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration, 2023.
  5. 5.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration, 2024.
  6. 6.Eli Lilly and Company. Mounjaro (tirzepatide) injection prescribing information. U.S. Food and Drug Administration, 2023.
  7. 7.Currax Pharmaceuticals. Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets prescribing information. U.S. Food and Drug Administration, 2021.
  8. 8.VIVUS LLC. Qsymia (phentermine and topiramate extended-release) capsules prescribing information. U.S. Food and Drug Administration, 2022.
  9. 9.U.S. Food and Drug Administration. Metformin hydrochloride tablets prescribing information. FDA, 2020.
  10. 10.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
  11. 11.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
  12. 12.Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice, 2016.
  13. 13.Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides